MIB-1 labelling index is an independent prognostic marker in primary breast cancer
1998

MIB-1 Labelling Index as a Prognostic Marker in Breast Cancer

Sample size: 341 publication Evidence: moderate

Author Information

Author(s): RLH Jansen, PSGJ Hupperets, JW Arends, SR Joosten-Achjanie, A Volovics, HC Schouten, HFP Hillen

Primary Institution: University Hospital Maastricht

Hypothesis

The MIB-1 labelling index is a significant prognostic factor in primary breast cancer.

Conclusion

The MIB-1 labelling index is an important prognostic factor for disease-free survival in patients with primary breast cancer.

Supporting Evidence

  • MIB-1 had prognostic value for disease-free survival in the whole group of patients.
  • MIB-1 was an independent prognostic factor besides axillary lymph node status.
  • High S-phase fraction was associated with decreased overall survival in univariate analysis.

Takeaway

This study found that a specific marker called MIB-1 can help doctors predict how well patients with breast cancer will do after treatment.

Methodology

The study analyzed the MIB-1 labelling index in 341 patients with primary breast cancer and compared it with the S-phase fraction in 220 patients.

Limitations

The follow-up period was relatively long, but the study may not have included enough diverse patient demographics.

Participant Demographics

Median age was 57 years, with a range from 25 to 87 years; 64.5% underwent modified radical mastectomy.

Statistical Information

P-Value

0.004

Statistical Significance

p<0.001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication